Elicera Therapeutics AB (ELIC) — Working Capital to Net Assets Ratio
Elicera Therapeutics AB (ELIC) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of Skr30.33 Million (current assets of Skr37.30 Million minus current liabilities of Skr6.97 Million) is measured against net assets of Skr30.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Elicera Therapeutics AB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Elicera Therapeutics AB Working Capital to Net Assets (2014–2024)
This chart shows how Elicera Therapeutics AB's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of Skr30.33 Million against net assets of Skr30.33 Million SEK. See Elicera Therapeutics AB defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Elicera Therapeutics AB (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Elicera Therapeutics AB from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Elicera Therapeutics AB (ELIC) market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.0% | Skr20.77 Million | Skr20.77 Million | Skr27.56 Million | Skr6.79 Million | ▲ +0.1 pp |
| 2023 | 99.9% | Skr16.39 Million | Skr16.40 Million | Skr30.17 Million | Skr13.78 Million | ▲ +1.5 pp |
| 2022 | 98.5% | Skr32.29 Million | Skr32.80 Million | Skr45.80 Million | Skr13.51 Million | ▼ -0.5 pp |
| 2021 | 99.0% | Skr51.71 Million | Skr52.24 Million | Skr54.21 Million | Skr2.50 Million | ▲ +4.2 pp |
| 2020 | 94.8% | Skr9.71 Million | Skr10.24 Million | Skr12.06 Million | Skr2.35 Million | ▲ +81.6 pp |
| 2019 | 13.2% | Skr80.92K | Skr614.10K | Skr84.92K | Skr4.00K | ▲ +6.3 pp |
| 2018 | 6.9% | Skr55.16K | Skr805.16K | Skr59.16K | Skr4.00K | ▼ -93.1 pp |
| 2017 | 100.0% | Skr808.69K | Skr808.69K | Skr812.69K | Skr4.00K | ▲ +0.0 pp |
| 2016 | 100.0% | Skr813.65K | Skr813.65K | Skr938.25K | Skr124.60K | ▲ +0.0 pp |
| 2015 | 100.0% | Skr818.47K | Skr818.47K | Skr1.19 Million | Skr366.76K | ▲ +0.0 pp |
| 2014 | 100.0% | Skr390.63K | Skr390.63K | Skr987.50K | Skr596.87K | — |